tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

IRTC Stock Latest News

iRhythm affirms FY23 revenue view of $475M-$485M, consensus $482.2M
The FlyiRhythm affirms FY23 revenue view of $475M-$485M, consensus $482.2M
11d ago
IRTC
iRhythm COO Douglas Devine steps down
The FlyiRhythm COO Douglas Devine steps down
11d ago
IRTC
BTIG finds medical technology stocks with exposure with SVB
The FlyBTIG finds medical technology stocks with exposure with SVB
14d ago
ATRC
HUMA
iRhythm provides update on investments with SVB Financial
The FlyiRhythm provides update on investments with SVB Financial
16d ago
IRTC
SIVB
iRhythm announces results of multiple new studies at ACC.23/WCC
The FlyiRhythm announces results of multiple new studies at ACC.23/WCC
20d ago
IRTC
Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors
Press ReleasesLarge Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors
20d ago
IRTC
Four New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCC
Press ReleasesFour New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCC
24d ago
IRTC
iRhythm price target raised to $143 from $135 at Canaccord
The FlyiRhythm price target raised to $143 from $135 at Canaccord
1M ago
IRTC
iRhythm Sees FY23 revenue $475M-$485M, consensus $485.6M
The FlyiRhythm Sees FY23 revenue $475M-$485M, consensus $485.6M
1M ago
IRTC
iRhythm reports Q4 EPS (67c), consensus (62c)
The FlyiRhythm reports Q4 EPS (67c), consensus (62c)
1M ago
IRTC
iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results
Press ReleasesiRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results
1M ago
IRTC
iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
Press ReleasesiRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
1M ago
IRTC
iRhythm initiated with an Overweight at Wells Fargo
The FlyiRhythm initiated with an Overweight at Wells Fargo
2M ago
IRTC
iRhythm shares preliminary Q4 highlights, business update
The FlyiRhythm shares preliminary Q4 highlights, business update
3M ago
IRTC
iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference
Press ReleasesiRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference
3M ago
IRTC
iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
Press ReleasesiRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
3M ago
IRTC
iRhythm price target lowered to $110 from $144 at Citi
The FlyiRhythm price target lowered to $110 from $144 at Citi
3M ago
IRTC
iRhythm management to meet virtually with BTIG
The FlyiRhythm management to meet virtually with BTIG
4M ago
IRTC
iRhythm management to meet virtually with BTIG
The FlyiRhythm management to meet virtually with BTIG
4M ago
IRTC
iRhythm management to meet virtually with BTIG
The FlyiRhythm management to meet virtually with BTIG
4M ago
IRTC
iRhythm upgraded to Peer Perform from Underperform at Wolfe Research
The FlyiRhythm upgraded to Peer Perform from Underperform at Wolfe Research
5M ago
IRTC
New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective
Press ReleasesNew Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective
5M ago
IRTC
iRhythm® Technologies Comments on the Final Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
Press ReleasesiRhythm® Technologies Comments on the Final Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
5M ago
IRTC
‘Stocks Are Looking Increasingly Cheap,’ Says J.P. Morgan; Here Are 2 Names to Consider
Stock Analysis & Ideas‘Stocks Are Looking Increasingly Cheap,’ Says J.P. Morgan; Here Are 2 Names to Consider
6M ago
IRTC
PTGX
iRhythm Technologies (NASDAQ:IRTC) Drops After Business Update
Market NewsiRhythm Technologies (NASDAQ:IRTC) Drops After Business Update
6M ago
IRTC
iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day
Press ReleasesiRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day
6M ago
IRTC
iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022
Press ReleasesiRhythm Technologies to Host Analyst & Investor Day on September 21, 2022
7M ago
IRTC
iRhythm Gains FDA Clearance for its Clinically Integrated ZEUS System
Press ReleasesiRhythm Gains FDA Clearance for its Clinically Integrated ZEUS System
8M ago
IRTC
iRhythm® Technologies Comments on the Proposed Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
Press ReleasesiRhythm® Technologies Comments on the Proposed Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
9M ago
IRTC
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.